CopdBevespi Aerosphere coupons
Bevespi Aerosphere

Bevespi Aerosphere Coupons & Savings Card – Discount Prices from $433.93

Bevespi Aerosphere is an inhaler designed for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults. It combines two medications: glycopyrrolate, a long-acting muscarinic antagonist (LAMA), and formoterol fumarate, a long-acting beta agonist (LABA). These medications work together by relaxing the muscles around the airways, helping to open them up and making breathing easier. This inhaler is used regularly, twice a day, and can be used with or without a spacer. It is important to note that Bevespi Aerosphere is not intended for the immediate relief of sudden breathing problems and should not be used for asthma treatment. If sudden shortness of breath occurs, a quick-relief inhaler should be used as prescribed. Although side effects are rare, they can include cough and urinary tract infections. Always consult a healthcare professional before starting or changing treatment regimens.
Our Bevespi Aerosphere coupons are free to use. You can print the coupon, email it to yourself, or receive the Bevespi Aerosphere coupon via text message. To get your free discount, show the pharmacist your Bevespi Aerosphere savings card which has the discounted coupon price. Use our filters below to edit the prescription box to match your needs. The Bevespi Aerosphere prices will update based on your prescription needs. Above our Bevespi Aerosphere coupons, you can change the location to see pharmacy prices in other areas. Our prescription discount card will update online with the specific pharmacy costs associated with your edits. Be sure to text, email, or print the Bevespi Aerosphere savings card code that you need after editing the prescription box and location field. Show the discount card to your pharmacist before paying.

My prescription

Edit

10.7GM of 9-4.8MCG/ACT, Bevespi Aerosphere (1 Inhaler)

Select pharmacy

Pharmacy logo

CVS

$438.59

COUPON PRICE
Pharmacy logo

Rite Aid

$433.93

COUPON PRICE
Pharmacy logo

Walmart

$442.61

COUPON PRICE
Pharmacy logo

Albertsons

$450.64

COUPON PRICE
Pharmacy logo

Walgreens

$453.60

COUPON PRICE

Bevespi Aerosphere savings card

Show this card to your pharmacist
Pharmacy logo

Rite Aid

$433.93

BIN

ID

PCN

GRP

019876

LH7F8F2E6C

CHIPPO

LHX

Powered by

This card is not insurance

More prescriptions for copd

coupons from$142.56Save 81%
coupons from$516.29Save 73%
coupons from$1.01Save 91%
coupons from$3.46Save 80%
coupons from$32.05Save 80%
coupons from$101.49Save 74%
coupons from$1561.20Save 45%
coupons from$1.45Save 98%

More prescriptions for copd

Anoro Ellipta Save 81%coupons from $142.56
Spiriva Respimat Save 73%coupons from $516.29
Theophylline Save 91%coupons from $1.01
Levalbuterol Hcl Save 80%coupons from $3.46
Ohtuvayre Save 80%coupons from $32.05
Theo-24 Save 74%coupons from $101.49
Yupelri Save 45%coupons from $1561.20
Acetylcysteine Save 98%coupons from $1.45

Price history for Bevespi Aerosphere (generic)

1, 10.7GM of 9-4.8MCG/ACT

Average retail price for Bevespi Aerosphere

Average SaveHealth price for Bevespi Aerosphere

Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.

Bevespi Aerosphere dosage forms

Use our Bevespi Aerosphere 10.7GM of 9-4.8MCG/ACT coupon with prices from $433.93 for 1 Inhaler.
DosageQuantityPrice fromPer unit
10.7GM of 9-4.8MCG/ACT1 Inhaler$433.93$433.93

Bevespi Aerosphere Warnings

The following information outlines critical safety considerations associated with the use of Bevespi Aerosphere (glycopyrrolate / formoterol). It is essential to review these details carefully and discuss any concerns with your healthcare provider.

  • Not for Acute COPD Episodes: Bevespi Aerosphere is not intended for use during sudden worsening of COPD symptoms, such as increased coughing or difficulty breathing. It is not a rescue inhaler. Consult your healthcare provider if symptoms persist or worsen.

  • Bronchospasm Risk: Inhalation of this medication can occasionally cause bronchospasm, leading to breathing difficulties, wheezing, or chest discomfort. If you experience difficulty breathing after using Bevespi, use a rescue inhaler and seek medical attention immediately.

  • Severe Allergic Reactions: There is a potential for severe allergic reactions, including anaphylaxis, characterized by symptoms such as facial swelling, rash, or difficulty breathing. Seek emergency medical help if these symptoms occur.

  • Cardiovascular Concerns: Formoterol may increase blood pressure and heart rate, or alter heart rhythms. These effects are rare if taken as prescribed. Regular monitoring of heart rate and blood pressure is advisable for those with pre-existing heart conditions. Inform your provider if you experience dizziness, rapid heartbeat, or tremors.

  • Ocular Risks: Bevespi Aerosphere may increase eye pressure and exacerbate glaucoma. Avoid spraying the medication in the eyes and consult an eye specialist if you notice any changes in vision.

  • Urinary Difficulty: Those with prostate problems should use this medication with caution, as it may exacerbate urination difficulties. Contact your healthcare provider if you experience this issue.

  • Hypokalemia: Excessive use of Bevespi Aerosphere can lead to low potassium levels, which are usually mild but can cause symptoms like muscle cramps or a racing heart. Report these symptoms to your healthcare provider.

Contraindications:

  • Do not use Bevespi Aerosphere for sudden shortness of breath or asthma attacks.
  • Avoid use if allergic to glycopyrrolate or formoterol.

Always consult your healthcare provider to ensure this medication is appropriate for your condition and to discuss any potential interactions with other drugs or substances.

Bevespi Aerosphere Side Effects

When taking this medication, it's important to be aware of potential side effects, ranging from mild to severe. Common side effects include a cough and urinary tract infections, which are typically mild. If these persist or become bothersome, consult your healthcare provider for advice. Other side effects that have been reported include chest pain, headaches, dizziness, and dry mouth. While these are generally not severe, you should reach out to your healthcare provider if they occur.

There are also more serious side effects, although they are rare. These include significant allergic reactions, which might manifest as hives, facial swelling, or difficulty breathing. If you experience sudden severe wheezing or trouble breathing, use your quick-relief inhaler and seek medical help immediately. Additionally, be vigilant for any signs of heart-related issues such as chest pain, irregular heartbeat, severe dizziness, or fainting, as these require urgent medical attention.

Monitor your blood pressure regularly, as this medication may cause an increase. Report high readings to your healthcare provider. If you notice symptoms like muscle cramps, increased thirst or urination, or any vision changes, contact your healthcare provider immediately. Always remember, this is not an exhaustive list of side effects. If you experience any other symptoms, it's important to consult with your healthcare provider.

Bevespi Aerosphere Interactions

Avoid using other long-acting beta-agonist (LABA) medications, like salmeterol or vilanterol, while taking this drug.
Bevespi Aerosphere FAQs
Is Bevespi Aerosphere a steroid?

Bevespi Aerosphere is not a steroid. It is a combination inhaler that contains two active ingredients: glycopyrrolate, a long-acting muscarinic antagonist (LAMA), and formoterol fumarate, a long-acting beta-agonist (LABA). It is used for the maintenance treatment of chronic obstructive pulmonary disease (COPD).

A comparable inhaler to Bevespi Aerosphere, which contains glycopyrrolate and formoterol, is Anoro Ellipta. Anoro Ellipta contains umeclidinium and vilanterol, which are also a combination of a long-acting muscarinic antagonist (LAMA) and a long-acting beta-agonist (LABA), similar to Bevespi. Both are used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). However, it is important for patients to consult with their healthcare provider to determine the most appropriate treatment for their specific condition.

A Bevespi inhaler is used for the maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It helps to improve breathing by relaxing the muscles around the airways in the lungs, making it easier for air to flow in and out. It is not intended for the relief of acute bronchospasm or as a rescue inhaler.

Symbicort and Bevespi are both inhalers used to manage chronic obstructive pulmonary disease (COPD), but they contain different active ingredients and have slightly different uses.Symbicort contains a combination of budesonide, a corticosteroid, and formoterol, a long-acting beta-agonist (LABA). It is used for both asthma and COPD to help reduce inflammation and relax the muscles in the airways, making breathing easier.Bevespi, on the other hand, contains glycopyrrolate, a long-acting muscarinic antagonist (LAMA), and formoterol, a LABA. It is specifically used for the maintenance treatment of COPD and works by relaxing and opening the airways in the lungs.In summary, the main difference lies in their active ingredients and specific indications, with Symbicort being used for both asthma and COPD, while Bevespi is used solely for COPD.

As of the latest information available, there is no generic equivalent for Bevespi Aerosphere. Bevespi is a combination inhaler containing formoterol and glycopyrrolate, used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). Patients should consult their healthcare provider for alternatives or updates on generic availability.